Literature DB >> 7684304

Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats.

S M Gardiner1, P A Kemp, T Bennett.   

Abstract

1. The effects of acute inhibition of nitric oxide (NO) synthase on cardiovascular responses to vasodilator challenges have already been described. We now report the responses to vasodilators during and after chronic NO synthase inhibition. 2. In conscious Brattleboro rats, the regional haemodynamic effects of 3 min infusions of acetylcholine (4 micrograms min-1), sodium nitroprusside (15 micrograms min-1) or adrenaline (0.2 micrograms min-1) were assessed (from areas under or over curves (AUC, AOC)) under control conditions, 6 and 72 h after the addition of the NO synthase inhibitor, NG-monomethyl-L-arginine (L-NMMA) to the drinking water (1 mg ml-1), and 6, 24 and 48 h after the withdrawal of L-NMMA. In a separate group of Brattleboro rats, responses to acetylcholine, sodium nitroprusside and adrenaline were assessed before and 6 h after the onset of oral ingestion of the more potent nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME; 0.05 mg ml-1). 3. Acetylcholine caused renal vasodilation (87 +/- 11 units) and mesenteric vasoconstriction (-31 +/- 5 units), sodium nitroprusside caused vasodilatation in renal (96 +/- 12 units), mesenteric (222 +/- 13 units) and hindquarters (49 +/- 15 units) vascular beds, whereas adrenaline caused hindquarters vasodilatation (92 +/- 8 units). Seventy two h after the onset of oral ingestion of L-NMMA, acetylcholine had a decreased renal vasodilator (59 +/- 9 units) effect, sodium nitroprusside had an increased renal vasodilator (142 +/- 23 units) action, while adrenaline had a decreased hindquarters vasodilator (55 +/- 6 units) influence. Twenty four h after withdrawal of L-NMMA, the renal vasodilator effect of acetylcholine was greater than the control response (106 +/- 14 units), but the regional haemodynamic effects of sodium nitroprusside and adrenaline were not different from those under control conditions. Hence, the increased renal vasodilator response to acetylcholine was probably due to changes in muscarinic receptor-mediated mechanisms rather than to any increase in guanylyl cyclase or its sensitivity to NO.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684304      PMCID: PMC2175574          DOI: 10.1111/j.1476-5381.1993.tb13557.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Can pulsed Doppler technique measure changes in aortic blood flow in conscious rats?

Authors:  S M Gardiner; A M Compton; T Bennett; C J Hartley
Journal:  Am J Physiol       Date:  1990-08

2.  Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo.

Authors:  S Moncada; D D Rees; R Schulz; R M Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 3.  Nitric oxide: physiology, pathophysiology, and pharmacology.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Pharmacol Rev       Date:  1991-06       Impact factor: 25.468

4.  Simple flow-thru swivel for infusions into unrestrained animals.

Authors:  Z W Brown; Z Amit; J R Weeks
Journal:  Pharmacol Biochem Behav       Date:  1976-09       Impact factor: 3.533

5.  Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples.

Authors:  E Theodorsson-Norheim
Journal:  Comput Biol Med       Date:  1987       Impact factor: 4.589

6.  Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.

Authors:  D D Rees; R M Palmer; R Schulz; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

7.  Regional haemodynamic changes during oral ingestion of NG-monomethyl-L-arginine or NG-nitro-L-arginine methyl ester in conscious Brattleboro rats.

Authors:  S M Gardiner; A M Compton; T Bennett; R M Palmer; S Moncada
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

8.  Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats.

Authors:  S M Gardiner; P A Kemp; T Bennett; R M Palmer; S Moncada
Journal:  Eur J Pharmacol       Date:  1992-03-31       Impact factor: 4.432

9.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

10.  Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.

Authors:  J R Haywood; R A Shaffer; C Fastenow; G D Fink; M J Brody
Journal:  Am J Physiol       Date:  1981-08
View more
  7 in total

1.  Role of endothelin-1 in the hyper-responsiveness to nitrovasodilators following acute NOS inhibition.

Authors:  Stephane L Bourque; Heather A Whittingham; Susan E Brien; Sandra T Davidge; Michael A Adams
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

2.  Contributions of nitric oxide synthases, dietary nitrite/nitrate, and other sources to the formation of NO signaling products.

Authors:  Alexandra B Milsom; Bernadette O Fernandez; Maria F Garcia-Saura; Juan Rodriguez; Martin Feelisch
Journal:  Antioxid Redox Signal       Date:  2012-01-18       Impact factor: 8.401

3.  Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.

Authors:  C E Bryant; G H Allcock; T D Warner
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

4.  Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

5.  Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses to vasodilators in conscious rats.

Authors:  S M Gardiner; P A Kemp; J E March; B Fallgren; T Bennett
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

6.  Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats.

Authors:  Ian D Wakefield; Julie E March; Philip A Kemp; Jean-Pierre Valentin; Terence Bennett; Sheila M Gardiner
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

7.  Cerebrovascular consequences of repeated exposure to NG-nitro-L-arginine methyl ester.

Authors:  P A Kelly; I M Ritchie; F M Collins
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.